Birchview Capital as of Dec. 31, 2022
Portfolio Holdings for Birchview Capital
Birchview Capital holds 57 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 37.0 | $52M | 728k | 71.95 | |
| Biodesix (BDSX) | 8.2 | $12M | 5.0M | 2.30 | |
| Neurocrine Biosciences (NBIX) | 7.1 | $10M | 84k | 119.44 | |
| Prothena Corp SHS (PRTA) | 5.4 | $7.7M | 127k | 60.25 | |
| Aziyo Biologics (ELUT) | 4.5 | $6.4M | 1.5M | 4.25 | |
| Quidel Corporation | 3.7 | $5.3M | 61k | 85.67 | |
| Encana Corporation (OVV) | 3.0 | $4.3M | 84k | 50.71 | |
| United Therapeutics Corporation (UTHR) | 2.9 | $4.2M | 15k | 278.07 | |
| ACADIA Pharmaceuticals (ACAD) | 2.8 | $4.0M | 249k | 15.92 | |
| Phreesia (PHR) | 1.9 | $2.7M | 83k | 32.36 | |
| Harrow Health (HROW) | 1.9 | $2.7M | 180k | 14.76 | |
| Albireo Pharma | 1.8 | $2.5M | 117k | 21.61 | |
| Masimo Corporation (MASI) | 1.6 | $2.3M | 15k | 147.97 | |
| Inhibrx | 1.2 | $1.7M | 70k | 24.64 | |
| Foghorn Therapeutics (FHTX) | 1.2 | $1.7M | 265k | 6.38 | |
| Accelr8 Technology | 1.1 | $1.6M | 2.3M | 0.71 | |
| Aveo Pharmaceuticals | 1.1 | $1.5M | 100k | 14.95 | |
| Alkermes SHS (ALKS) | 0.9 | $1.3M | 50k | 26.14 | |
| Cytokinetics (CYTK) | 0.8 | $1.1M | 25k | 45.84 | |
| Alphatec Holdings (ATEC) | 0.8 | $1.1M | 90k | 12.36 | |
| Corcept Therapeutics Incorporated (CORT) | 0.7 | $1.0M | 50k | 20.32 | |
| Karyopharm Therapeutics (KPTI) | 0.7 | $991k | 291k | 3.40 | |
| Equitrans Midstream Corp (ETRN) | 0.6 | $891k | 133k | 6.70 | |
| Pioneer Natural Resources | 0.6 | $868k | 3.8k | 228.42 | |
| Docgo (DCGO) | 0.5 | $778k | 110k | 7.07 | |
| ImmunoGen | 0.5 | $744k | 150k | 4.96 | |
| Ventyx Biosciences (VTYX) | 0.5 | $721k | 22k | 32.77 | |
| Bluebird Bio (BLUE) | 0.5 | $678k | 98k | 6.92 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $621k | 12k | 51.75 | |
| Halozyme Therapeutics (HALO) | 0.4 | $569k | 10k | 56.90 | |
| 2seventy Bio (TSVT) | 0.4 | $561k | 60k | 9.38 | |
| Iveric Bio | 0.4 | $535k | 25k | 21.40 | |
| Silk Road Medical Inc Common | 0.4 | $529k | 10k | 52.90 | |
| Arvinas Ord (ARVN) | 0.4 | $513k | 15k | 34.20 | |
| Soleno Therapeutics | 0.3 | $485k | 245k | 1.98 | |
| Kiniksa Pharmaceuticals | 0.3 | $449k | 30k | 14.97 | |
| Protagonist Therapeutics (PTGX) | 0.3 | $415k | 38k | 10.92 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $394k | 10k | 39.40 | |
| 10x Genomics Cl A Com (TXG) | 0.3 | $364k | 10k | 36.40 | |
| Amicus Therapeutics (FOLD) | 0.2 | $342k | 28k | 12.21 | |
| Keros Therapeutics (KROS) | 0.2 | $336k | 7.0k | 48.00 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $324k | 2.5k | 129.60 | |
| Xencor (XNCR) | 0.2 | $320k | 12k | 26.02 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $270k | 40k | 6.75 | |
| Nektar Therapeutics (NKTR) | 0.2 | $267k | 118k | 2.26 | |
| Cullinan Oncology (CGEM) | 0.2 | $265k | 25k | 10.55 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $230k | 20k | 11.50 | |
| G1 Therapeutics | 0.2 | $217k | 40k | 5.42 | |
| Inflarx Nv (IFRX) | 0.2 | $217k | 70k | 3.10 | |
| Gossamer Bio (GOSS) | 0.2 | $215k | 99k | 2.17 | |
| Stoke Therapeutics (STOK) | 0.1 | $138k | 15k | 9.20 | |
| Concert Pharmaceuticals I equity | 0.1 | $117k | 20k | 5.85 | |
| Biohaven Pharmaceutical Holding | 0.1 | $102k | 7.4k | 13.85 | |
| Angion Biomedica Corp | 0.0 | $44k | 54k | 0.81 | |
| Yield10 Bioscience | 0.0 | $31k | 19k | 1.65 | |
| Aspira Womens Health | 0.0 | $20k | 60k | 0.33 | |
| Sientra | 0.0 | $8.0k | 40k | 0.20 |
